Summarized by AI Model:Overglitch/t5-small-cnn-dailymail
PBR Life Sciences is a healthtech business that specialises in anonymised healthcare big data . In order to expand its operations throughout Africa, PBR has acquired $1 million in pre-seed capital . PBR will be able to fortify its operations and penetrate new markets .To expand AI-driven healthcare data platforms throughout Africa, PBR Life Sciences has secured $1 million in pre-seed funding. In order to expand its operations throughout Africa, PBR Life Sciences, a healthtech business that specialises in anonymised healthcare big data, has acquired $1 million in pre-seed capital.
Launch Africa, Microtraction, Kaleo Ventures, Octerra Capital, and ARM Labs were among the prominent sponsors who spearheaded the venture. PBR will be able to fortify its operations and penetrate new markets like Ghana and Kenya thanks to the finance. Ayodeji Alaran, the CEO of the company, claims that the funding will increase the startup’s influence throughout the continent while assisting in keeping a laser-like focus on profitability.
When PBR Life Sciences was first established in 2015, its focus was on filling in the gaps in Nigeria’s medical data. After identifying significant obstacles in data accessibility, Alaran—a chemist with an MBA and a wealth of expertise at GSK, Pfizer, and AstraZeneca—led a strategic change in 2021 to offer big data solutions for Sub-Saharan Africa.
In order to give pharmaceutical businesses information about product performance, market trends, and competitor analysis, PBR’s flagship platform, “Versus,” gathers data from retail pharmacies. The platform helps healthcare organisations improve decision-making, resource management, and care delivery by utilising AI and machine learning.
By guaranteeing the inclusion of under-represented patient groups, PBR plays a crucial part in advancing inclusivity in clinical trials. After the company joined the Techstars Lagos accelerator, which supports high-growth African startups, it began to gain traction. PBR strengthened its status as a top provider of healthcare data during the program by growing its network and obtaining $120,000 in funding.
PBR uses data-driven insights to process millions of data points throughout Africa, assisting in the resolution of complicated health issues. Investors are confident that the business can revolutionise healthcare data access across the continent. Launch Africa emphasised PBR’s capable leadership and calculated approach to addressing urgent healthcare issues.
Octerra Capital reaffirmed its commitment to supporting PBR’s objective and reaffirmed its conviction in the company’s capacity to transform health data accessible. PBR Life Sciences is in a position to significantly influence how data is utilised to improve care and results throughout Africa as the continent’s healthcare systems become more sophisticated.
